Device Trial Radar · NCT06664788
A Study of ETHIZIA Versus SURGICEL Original in Controlling Soft Tissue Bleeding During Open Surgery
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
108
Actual
Start
Apr 16, 2025
Primary completion
Sep 3, 2026
Study completion Oct 7, 2026
Sponsor
- Lead sponsor
- Ethicon, Inc.Public (JNJ)
- Sponsor type
- Industry
- First posted
- Oct 30, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this clinical investigation is to evaluate the safety and efficacy of ETHIZIA to control minimal, mild, or moderate soft tissue bleeding during open surgery when compared to SURGICEL Original in the percentage of cases achieving hemostasis at 3 minutes after product application, and without re-bleeding up to 10 minutes after application.
Conditions
- Hemostasis
- Hemostatic Techniques
Interventions
ETHIZIADevice
ETHIZIA patch will be applied to bleeding site intraoperatively.
SURGICEL OriginalDevice
SURGICEL Original will be applied to bleeding site intraoperatively.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Cases Achieving Hemostasis at Three Minutes Following Product Application And With No Rebleeding Up to 10 Minutes Following Application at The Target Bleeding SiteTime frame: Intraoperative (up to 10 minutes)
Locations
7 sites in 2 countries. Site status is shown where the registry gives one.
Keck Hospital of USC
Los Angeles, California
Washington University Barnes Jewish Hospital
St Louis, Missouri
Capital Health Medical Center - Hopewell
Pennington, New Jersey
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.